January 20, 2009

 

Press Release no.1

Recommencement of trading pursuant to scheme of capital reduction - NEOCURE

 

The trading in equity shares of Neocure Therapeutics Ltd shall be recommenced on the Exchange pursuant to scheme of capital reduction w.e.f. January 22, 2009. Trading shall be in the Normal Market Segment – Compulsory Demat (Rolling Settlement) for all investors.

 

Sr. No.

Symbol

Name of the Company

ISIN Code

1

NEOCURE

Neocure Therapeutics Ltd

INE695B01025

 

 

Press Release no.2

NSE completes its 2229th Normal Settlement

 

The Exchange has successfully completed its 2229th Normal Settlements (Rolling T+2 following SEBI directive) since inception i.e., Settlement Numbers N – 2009011 on Jan 20, 2009. The settlement statistics is as follows:      

 

Particulars
Values

 

N-2009011

Total traded quantity (lakhs)

6084.73

Total traded value (Rs. In Crores)

7267.62

Total value of the settlement (Securities) (Rs. In Crores)

1396.93

Total value of the settlement (Funds) (Rs. In Crores)

528.18

Shortages for the settlement

0.13%

% of  Delivery ( No. of shares deliverable / No. of shares traded )

18.51%

 

Retail Debt Market have completed its 1503rd settlements detail of which are as follows:

 

Settlement No.

Traded Value

Settlement Value

 

 

Securities

Funds

D- 2009011

NIL

NIL

NIL